Prescription drug · ANDA
Liothyronine Sodium NDC 71205-150
Liothyronine sodium 5 ug/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-150-30 | 7120501503071205015030 | 30 TABLET in 1 BOTTLE (71205-150-30)Marketed from Nov 1, 2018 | |
| 71205-150-60 | 7120501506071205015060 | 60 TABLET in 1 BOTTLE (71205-150-60)Marketed from Nov 1, 2018 | |
| 71205-150-90 | 7120501509071205015090 | 90 TABLET in 1 BOTTLE (71205-150-90)Marketed from Nov 1, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Liothyronine Sodium
- Generic name (nonproprietary)
- liothyronine sodium
- Active ingredients
- Liothyronine sodium — 5 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LPNDC labeler code 71205
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 200295
- Marketing start
- Listing expires
- Other FDA classes
- Triiodothyronine (Chemical structure)
- Identifiers
- Product ID 71205-150_7c4088ea-921d-440c-ae1c-c473fc381e50SPL ID 7c4088ea-921d-440c-ae1c-c473fc381e50SPL set ID f882d34f-6b9f-4d9d-8a3e-3054ba91c506RxCUI 903456UNII GCA9VV7D2NUPC 0371205150303
- Pharmacologic class
- l-Triiodothyronine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205015030followed by a unit qualifier and the quantityPackage 71205-0150-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Thyroid hormone drugs are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema and ordinary hypothyroidism in patients of any age (pediatric patients, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary) or tertiary (hypothalamic) hypothyroidism (see WARNINGS ). 2. A…
Excerpt only. Read the full label for complete information.
About NDC 71205-150
- What is NDC 71205-150?
- 71205-150 is the product NDC for Liothyronine Sodium, Liothyronine sodium 5 ug/1 tablet, listed with the FDA by Proficient Rx LP. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Liothyronine Sodium.
- What is the active ingredient?
- Liothyronine sodium.
- Who is the labeler?
- Proficient Rx LP, NDC labeler code 71205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Liothyronine Sodium?
- 44 other product NDCs are listed under this name. See all Liothyronine Sodium NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Liothyronine Sodium products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Liothyronine Sodium | Liothyronine sodium 25 ug/1 | TabletOral | Dr. Reddy's Labratories Inc. | 75907-001 | 75907-0001-01 |
| Liothyronine Sodium | Liothyronine sodium 50 ug/1 | TabletOral | Dr. Reddy's Labratories Inc. | 75907-004 | 75907-0004-01 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | Dr. Reddy's Labratories Inc. | 75907-039 | 75907-0039-01 |
| Liothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | Biocon Pharma Inc. | 70377-114 | 70377-0114-1170377-0114-1270377-0114-13 |
| Liothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | Biocon Pharma Inc. | 70377-115 | 70377-0115-1170377-0115-1270377-0115-13 |
| Liothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | Biocon Pharma Inc. | 70377-116 | 70377-0116-1170377-0116-1270377-0116-13 |
| Liothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | Northstar Rx LLC | 16714-166 | 16714-0166-01 |
| Liothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | Northstar Rx LLC | 16714-167 | 16714-0167-01 |
| Liothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | Northstar Rx LLC | 16714-168 | 16714-0168-01 |
| Liothyronine Sodium | Liothyronine sodium 25 ug/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-2178 | 00093-2178-01 |
Other NDCs under ANDA 200295
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Liomnyliothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | SIGMAPHARM LABORATORIES, LLC | 42794-131 |
| Liomnyliothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | SIGMAPHARM LABORATORIES, LLC | 42794-132 |
| Liomnyliothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | SIGMAPHARM LABORATORIES, LLC | 42794-133 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | SIGMAPHARM LABORATORIES, LLC | 42794-018 |
| Liothyronine Sodium | Liothyronine sodium 25 ug/1 | TabletOral | SIGMAPHARM LABORATORIES, LLC | 42794-019 |
| Liothyronine Sodium | Liothyronine sodium 50 ug/1 | TabletOral | SIGMAPHARM LABORATORIES, LLC | 42794-020 |
| Liothyronine Sodium | Liothyronine sodium 25 ug/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 43063-884 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | A-S Medication Solutions | 50090-3131 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3571 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-7269 |
| Liothyronine Sodium | Liothyronine sodium 25 ug/1 | TabletOral | Bryant Ranch Prepack | 71335-0166 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | Bryant Ranch Prepack | 71335-0341 |
| Liothyronine Sodium | Liothyronine sodium 50 ug/1 | TabletOral | Bryant Ranch Prepack | 71335-9632 |
| Liothyronine Sodium | Liothyronine sodium 5 ug/1 | TabletOral | ASCLEMED USA INC. | 87063-080 |
| Liothyronine Sodium | Liothyronine sodium 25 ug/1 | TabletOral | ASCLEMED USA INC. | 87063-081 |
| Liothyronine Sodium | Liothyronine sodium 50 ug/1 | TabletOral | ASCLEMED USA INC. | 87063-082 |